Testing effectiveness (Phase 2)UnknownNCT06331650
What this trial is testing
A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer
Who this might be right for
Non-small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease 30